Literature DB >> 23507089

The chaperone Hsp90: changing partners for demanding clients.

Alina Röhl1, Julia Rohrberg, Johannes Buchner.   

Abstract

The heat shock protein (Hsp)90 chaperone machinery regulates the activity of hundreds of client proteins in the eukaryotic cytosol. It undergoes large conformational changes between states that are similar in energy. These transitions are rate-limiting for the ATPase cycle. It has become evident that several of the many Hsp90 co-chaperones affect the conformational equilibrium by stabilizing specific intermediate states. Consequently, there is an ordered progression of different co-chaperones during the conformational cycle. Asymmetric complexes containing two different co-chaperones may be important for the processing of the client protein, although our understanding of this aspect, as well as the details of the interaction of Hsp90 with client proteins, is still in its infancy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507089     DOI: 10.1016/j.tibs.2013.02.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  115 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

2.  The C-terminal domain of human Cdc37 studied by solution NMR.

Authors:  Ziming Zhang; Dimitra Keramisanou; Amit Dudhat; Michael Paré; Ioannis Gelis
Journal:  J Biomol NMR       Date:  2015-09-24       Impact factor: 2.835

Review 3.  RNAi in Plants: An Argonaute-Centered View.

Authors:  Xiaofeng Fang; Yijun Qi
Journal:  Plant Cell       Date:  2016-02-11       Impact factor: 11.277

Review 4.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

5.  A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.

Authors:  Mathias Riebold; Christian Kozany; Lee Freiburger; Michael Sattler; Michael Buchfelder; Felix Hausch; Günter K Stalla; Marcelo Paez-Pereda
Journal:  Nat Med       Date:  2015-02-09       Impact factor: 53.440

Review 6.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

Review 7.  Comparing protein folding in vitro and in vivo: foldability meets the fitness challenge.

Authors:  Karan S Hingorani; Lila M Gierasch
Journal:  Curr Opin Struct Biol       Date:  2014-01-14       Impact factor: 6.809

8.  Hsp90 Maintains Proteostasis of the Galactose Utilization Pathway To Prevent Cell Lethality.

Authors:  Rajaneesh Karimpurath Gopinath; Jun-Yi Leu
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

9.  Designed Hsp90 heterodimers reveal an asymmetric ATPase-driven mechanism in vivo.

Authors:  Parul Mishra; Daniel N A Bolon
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

10.  Stromal cell-derived factor 2 is critical for Hsp90-dependent eNOS activation.

Authors:  Mauro Siragusa; Florian Fröhlich; Eon Joo Park; Michael Schleicher; Tobias C Walther; William C Sessa
Journal:  Sci Signal       Date:  2015-08-18       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.